Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Bioinorganic Chemistry Conference 2013

19 Feb 2013 - 22 Feb 2013 - Lanzarote, Spain



Bookmark and Share


Metals are receiving ever-increasing recognition for their roles in biological processes. It is estimated that over one third of all proteins contain at least one metal ion as essential prosthetic group, and it is well recognized that those metallobiomolecules are of key importance for a large number of biological reactions and phenomena, including electron transfer, oxidation reactions involved in metabolism and catabolism, hydrolysis reactions, synthesis and metabolic function of genes, regulation of protein expression, cell signalling, etc.. A detailed understanding of the regulation and molecular mechanisms of metalloprotein function is not only of fundamental interest, but is of great importance to the pharmaceutical, agricultural, biotechnological, and environmental industries. In the end it may also pave the way for various technological applications of the principles of biocatalysis, since metalloenzymes are capable of carrying out energetically difficult chemical transformations (such as the fixation of dinitrogen to ammonia or the oxidation of methane to methanol) under mild and environmentally safe conditions. Emulating the unique reactivity of metalloenzymes by small synthetic complexes for the ultimate goal of catalytic applications is thus a formidable task. This conference now brings together chemists, biologists and biophysicists that interrogate the role of metal ions in biological systems, using both experimental and theoretical approaches. The conference provides a stimulating and interdisciplinary environment for both senior scientists and young researchers to discuss latest progress in the field of bioinorganic chemistry, with topics ranging from structural biology to bioinspired coordination chemistry and medicinal applications of metallodrugs.



Further information
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!